The annual public report from the Joint Drug Prevention and Treatment Program’s Independent Program Administrator has been released by Major League Baseball. The stats:
- There were 5,391 total drug tests. 4,022 were urine samples, 1,369 were blood samples;
- There were eight positive tests resulting in discipline. All were for stimulants. Seven of the stimulant tests were for Adderall. One for Methylhexaneamine. I guess that means that there are no more steroids in baseball. Yay!
- There were 13 “non-analytical positives.” That’s baseball code for “Biogenesis dudes.”
- There were 122 therapeutic use exemptions for otherwise banned drugs. 119 of them were for ADD drugs like Adderall. Three were three for hypogonadism. A couple of years ago here was only one for hypogonadism, so that’s on the uptick. On the bright side, two years ago there was a therapeutic use exemption for narcolepsy and now there is none. So the narcoleptic either got better or retired.
The most interesting thing here, to me anyway, continues to be the number of Adderall-users in baseball. It’s estimated that 4.7% of the adult population has ADD. 119 of roughly 1,200 major leaguers on 40-man rosters puts the ADD rate at nearly 10%. Back that number down a little bit for the various guys that shuffle in and out of 400-man rosters and you figure that baseball players have ADD diagnosis at around twice the level of that in the normal population.
Are baseball players more likely to have ADD than the rest of the adult population? Are they just more likely to be diagnosed that way? Or are therapeutic use exemptions for ADD drugs a means of getting something ballplayers have always found beneficial — stimulants — in a legal way?
A report from the Baltimore Sun’s Dan Connolly suggests that free agent catcher Welington Castillo currently tops the Orioles’ list of potential backstop targets for the 2017 season. With Matt Wieters on the market, the Orioles lack a suitable platoon partner for Caleb Joseph behind the dish, and Connolly adds that the club has been discussing a multi-year deal with Castillo’s representatives since the Winter Meetings.
Castillo batted .264/.322/.423 with the Diamondbacks in 2016, racking up 14 home runs and driving in a career-high 68 RBI in 457 PA. His bat provides much of his upside, and Connolly quoted an anonymous National League scout who believes that the 29-year-old’s defensive profile has fallen short of his potential in recent years.
For better or worse, both the Orioles and Castillo appear far from locking in a deal for 2017. Both the Rays and Braves have expressed interest in the veteran catcher during the past week, while the Orioles are reportedly considering Wieters, Nick Hundley and Chris Iannetta as alternatives behind the plate.
The Phillies reportedly signed veteran outfielder Daniel Nava to a minor league contract, according to Matt Gelb of the Philadelphia Inquirer.
Nava began the season on a one-year contract with the Angels, during which he slashed .235/.309/.303 through 136 PA in the first half of 2016. He was flipped to the Royals in late August for a player to be named later and saw the remainder of his year go down the drain on an .091 average through 12 PA in Anaheim. After getting the boot from the Angels’ 40-man roster in November, the 33-year-old outfielder elected free agency.
Nava is expected to compete for a bench role on the Phillies’ roster in the spring. As it currently stands, the club’s projected 2017 outfield features Howie Kendrick and Odubel Herrera, with precious little depth behind them. Nava’s bat is underwhelming, but at the very least he offers the Phillies a warm body in left field and a potential platoon partner for one of their younger options, a la Tyler Goeddel or Roman Quinn.